Galmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients

Media coverage

• Title	Galmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
  Media name/outlet	M2 Pharma
  Country/Territory	United States
  Date	1/11/21
  Persons	Scott Friedman

• Title	Galmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
  Media name/outlet	M2Pharma.com
  Country/Territory	United States
  Date	1/11/21
  URL	m2pharma.com/news/policy-and-regulations/article.php?id=94644
  Persons	Scott Friedman

• Title	Galmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
  Media name/outlet	M2 EquityBites
  Country/Territory	United Kingdom
  Date	1/11/21
  Persons	Scott Friedman

• Title	Galmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
  Media name/outlet	FinancialWire
  Country/Territory	Australia
  Date	1/11/21
  Persons	Scott Friedman